PMV Pharmaceuticals Inc (PMVP)
1.745
+0.04
(+2.05%)
USD |
NASDAQ |
Apr 26, 12:08
PMV Pharmaceuticals Cash from Investing (TTM): -50.54M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -50.54M |
September 30, 2023 | -24.73M |
June 30, 2023 | 38.42M |
March 31, 2023 | 87.10M |
December 31, 2022 | -1.368M |
September 30, 2022 | -17.03M |
June 30, 2022 | -47.24M |
Date | Value |
---|---|
March 31, 2022 | -42.51M |
December 31, 2021 | -143.58M |
September 30, 2021 | -151.20M |
June 30, 2021 | -142.47M |
March 31, 2021 | -105.60M |
December 31, 2020 | 27.91M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-151.20M
Minimum
Sep 2021
87.10M
Maximum
Mar 2023
-44.07M
Average
-42.51M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Exelixis Inc | -26.96M |
Geron Corp | -180.32M |
Verastem Inc | -44.45M |
Karyopharm Therapeutics Inc | 7.94M |
Kura Oncology Inc | 15.56M |